A Study of Lenvatinib (MK-7902) in Pediatric Participants with Relapsed or Refractory Solid Malignancies (MK-7902-013/E7080)

Trial Identifier: 7902-013
Sponsor: MSD
Collaborator:
Eisai
Start Date: July 2020
Primary Completion Date: September 2022
Study Completion Date: February 2025
Condition: Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
Results Plain Language Summary - Italian
Results Plain Language Summary - Russian
Results Plain Language Summary - Belgium French
Results Plain Language Summary - Serbian
Results Plain Language Summary - Czech
Results Plain Language Summary - Croatian
Results Plain Language Summary - English
Results Plain Language Summary - Hungarian
Results Plain Language Summary - French
Results Plain Language Summary - LATAM Spanish
Results Plain Language Summary - Belgium Dutch
Protocol Plain Language Summary - English
Results Plain Language Summary - Spanish
Results Plain Language Summary - Belgium German
Results Plain Language Summary - Turkish

Trial Locations

Country Location
Argentina, Buenos Aires Pilar, Buenos Aires, Argentina, B1629ODT
Argentina, CABA Ciudad Autonoma de Buenos Aires, CABA, Argentina, C1425EFD
Australia, New South Wales Randwick, New South Wales, Australia, 2031
Australia, Queensland Brisbane, Queensland, Australia, 4101
Australia, Victoria Parkville, Victoria, Australia, 3052
Australia, Western Australia Nedlands, Western Australia, Australia, 6009
Belgium, Oost-Vlaanderen Gent, Oost-Vlaanderen, Belgium, 9000
Croatia, Primorsko-goranska zupanija Rijeka, Primorsko-goranska zupanija, Croatia, 51000
Croatia, Zagrebacka zupanija Zagreb, Zagrebacka zupanija, Croatia, 10000
Czech Republic, Brno-mesto Brno, Brno-mesto, Czech Republic, 613 00
Czech Republic, Praha 5 Praha 5, Czech Republic, 150 06
France, Auvergne Lyon, Auvergne, France, 69008
France, Bouches-du-Rhone Marseille, Bouches-du-Rhone, France, 13005
France, Paris Paris, France, 75005
France, Val-de-Marne Villejuif, Val-de-Marne, France, 94800
Guatemala, Guatemala Guatemala, Guatemala, 01016
Guatemala, Guatemala Guatemala, Guatemala, 01011
Hungary, Borsod-Abauj-Zemplen Miskolc, Borsod-Abauj-Zemplen, Hungary, 3526
Hungary, Budapest Budapest, Hungary, 1094
Hungary, Debrecen Debrecen, Hungary, 4032
Israel, N/A Ramat-Gan, N/A, Israel, 5265601
Italy, Genova Genova, Italy, 16147
Italy, Milano Milano, Italy, 20133
Italy, Roma Rome, Roma, Italy, 00165
Italy, Torino Torino, Italy, 10126
Italy, Toscana Firenze, Toscana, Italy, 50139
Korea, Republic of, Seoul Seoul, Korea, Republic of, 03080
Korea, Republic of, Seoul Songpagu, Seoul, Korea, Republic of, 05505
New Zealand, Auckland Auckland, New Zealand, 1023
Peru, Lima San Isidro, Lima, Peru, 15073
Russian Federation, Moskva Moscow, Moskva, Russian Federation, 117198
Russian Federation, Sankt-Peterburg Saint Petersburg, Sankt-Peterburg, Russian Federation, 197022
Russian Federation, Sankt-Peterburg Saint-Petersburg, Sankt-Peterburg, Russian Federation, 197758
Serbia, Beograd Belgrade, Beograd, Serbia, 11000
Serbia, Beograd Beograd, Serbia, 11000
South Africa, Gauteng Soweto, Gauteng, South Africa, 2013
South Africa, Western Cape Cape Town, Western Cape, South Africa, 7700
South Africa, Western Cape Parow, Western Cape, South Africa, 7505
Spain, Barcelona Esplugues de Llobregat, Barcelona, Spain, 08950
Spain, Madrid Madrid, Spain, 28009
Sweden, Skane lan Lund, Skane lan, Sweden, 221 85
Turkey, Ankara Ankara, Turkey, 06100
Turkey, Istanbul Istanbul, Turkey, 34093
Turkey, Izmir Izmir, Turkey, 35040
Turkey, Izmir Izmir, Turkey, 35330
United States, CO Aurora, CO, United States, 80045
United States, OH Cleveland, OH, United States, 44195
United States, TN Nashville, TN, United States, 37232
United States, TX Dallas, TX, United States, 75230